AI consulting for small and mid-size pharma.

We are an AI consultancy for small and mid-size pharma. We find the work that eats your team's week, build AI agents to handle it, and maintain them after handoff. Everything runs inside Claude Enterprise, with a HIPAA BAA available and a 21 CFR Part 11 evaluation on request.

Most big-firm AI projects end in a slide deck. Ours end in something your team uses on Monday. And you work with one person the whole way through, the one who scoped the build and who still picks up when it breaks six months later.

What we take off your plate

• Protocol amendments and the impact assessments that trail them.
• Regulatory drafting, from first synopsis to submission-ready text.
• Literature search and evidence pulls that used to swallow a medical writer's afternoon.
• Inbound intake that arrives after hours and goes unanswered until morning.

One we shipped

A mid-size sponsor was bleeding weeks into protocol amendments and regulatory drafting. We put the drafting and review on an Agentic OS. It freed $150,000 of medical-writer time and $50,000 of reviewer time, and cut amendment turnaround enough to recover another $80,000. That is $280,000 in the first year on a $25,000 build.

Mid-size sponsor. $280,000 first-year saving. $25,000 build.

Built for regulated work

Procurement and quality will ask hard questions before any agent touches your data. We answer them up front. Read how we handle HIPAA, the BAA, and 21 CFR Part 11, or look at the related work in regulatory affairs and clinical operations.

Common questions